Hepatology communications
Prospective comparative assessment of liver stiffness and steatosis between iLivTouch and FibroScan
Von Nuñez-Mercado F, Juárez-Hernández E, Gómez-Mendoza RA und 4 weiteren.
Inhalt auf Englisch
Abstract
Background
Metabolic dysfunction-associated steatotic liver disease currently represents the leading cause of chronic liver disease worldwide. FibroScan and iLivTouch are 2 devices that employ similar principles to estimate liver steatosis and fibrosis, although few studies have directly compared their results.
Aim
To evaluate the concordance of 2 transient elastography devices for the estimation of liver steatosis and fibrosis.